• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Epidemiol . Early prediction of mortality risk among patients with severe COVID-19, using machine learning

tetano

Editor, Senior Moderator
Int J Epidemiol


. 2020 Sep 23;dyaa171.
doi: 10.1093/ije/dyaa171. Online ahead of print.
Early prediction of mortality risk among patients with severe COVID-19, using machine learning


Chuanyu Hu[SUP] 1 [/SUP], Zhenqiu Liu[SUP] 2 3 [/SUP], Yanfeng Jiang[SUP] 2 3 [/SUP], Oumin Shi[SUP] 4 [/SUP], Xin Zhang[SUP] 5 6 [/SUP], Kelin Xu[SUP] 7 [/SUP], Chen Suo[SUP] 5 6 [/SUP], Qin Wang[SUP] 1 [/SUP], Yujing Song[SUP] 1 [/SUP], Kangkang Yu[SUP] 8 [/SUP], Xianhua Mao[SUP] 2 3 [/SUP], Xuefu Wu[SUP] 5 6 [/SUP], Mingshan Wu[SUP] 5 6 [/SUP], Tingting Shi[SUP] 5 [/SUP], Wei Jiang[SUP] 2 3 [/SUP], Lina Mu[SUP] 9 [/SUP], Damien C Tully[SUP] 10 [/SUP], Lei Xu[SUP] 11 [/SUP], Li Jin[SUP] 2 3 [/SUP], Shusheng Li[SUP] 1 [/SUP], Xuejin Tao[SUP] 1 [/SUP], Tiejun Zhang[SUP] 5 6 [/SUP], Xingdong Chen[SUP] 2 3 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, has been spreading globally. We aimed to develop a clinical model to predict the outcome of patients with severe COVID-19 infection early.
Methods: Demographic, clinical and first laboratory findings after admission of 183 patients with severe COVID-19 infection (115 survivors and 68 non-survivors from the Sino-French New City Branch of Tongji Hospital, Wuhan) were used to develop the predictive models. Machine learning approaches were used to select the features and predict the patients' outcomes. The area under the receiver operating characteristic curve (AUROC) was applied to compare the models' performance. A total of 64 with severe COVID-19 infection from the Optical Valley Branch of Tongji Hospital, Wuhan, were used to externally validate the final predictive model.
Results: The baseline characteristics and laboratory tests were significantly different between the survivors and non-survivors. Four variables (age, high-sensitivity C-reactive protein level, lymphocyte count and d-dimer level) were selected by all five models. Given the similar performance among the models, the logistic regression model was selected as the final predictive model because of its simplicity and interpretability. The AUROCs of the external validation sets were 0.881. The sensitivity and specificity were 0.839 and 0.794 for the validation set, when using a probability of death of 50% as the cutoff. Risk score based on the selected variables can be used to assess the mortality risk. The predictive model is available at [https://phenomics.fudan.edu.cn/risk_scores/].
Conclusions: Age, high-sensitivity C-reactive protein level, lymphocyte count and d-dimer level of COVID-19 patients at admission are informative for the patients' outcomes.

Keywords: COVID-19; death; fatality rate; machine learning; predictive model.
 
Back
Top Bottom